RH ANTIBODY TITRE (ANTI D/COOMBS TITRE- AUTOMATED)

The Rh Antibody Titre (Anti-D/Coombs Titre – Automated) Test is a specialized immunohematology test used to measure the concentration of Anti-D antibodies in the blood. The test plays a critical role in monitoring Rh-negative individuals, particularly pregnant women, who may develop antibodies against Rh-positive red blood cells.

Rh sensitization, also known as Rh alloimmunization, occurs when an Rh-negative person is exposed to Rh-positive red blood cells. This exposure may happen during pregnancy, blood transfusion, miscarriage, ectopic pregnancy, or certain obstetric procedures. Once sensitized, the immune system may produce Anti-D antibodies that can cross the placenta and attack fetal red blood cells in future pregnancies.

The Rh Antibody Titre test helps determine the strength and concentration of these antibodies. Automated testing methods provide accurate and standardized measurement of antibody levels, enabling physicians to assess risk and guide pregnancy management.

This test is commonly used alongside the Indirect Coombs Test (Indirect Antiglobulin Test) and forms an essential part of prenatal care for Rh-negative mothers carrying an Rh-positive fetus.

Benefits of the Test

• Measures Anti-D antibody levels accurately
• Monitors Rh sensitization during pregnancy
• Assesses risk of fetal hemolytic disease
• Supports management of Rh alloimmunization
• Helps guide obstetric monitoring
• Provides standardized automated testing results

Why Doctors Recommend This Test

Doctors may recommend the Rh Antibody Titre Test for:

• Rh-negative pregnant women
• Monitoring known Rh sensitization
• Previous history of Rh incompatibility
• Evaluation after blood transfusion reactions
• Assessment of alloantibodies during pregnancy
• Monitoring risk of Hemolytic Disease of the Fetus and Newborn (HDFN)
• Follow-up of positive antibody screening results

The test helps determine whether antibody levels are increasing and whether additional fetal monitoring is required.

Preparation Before Test

The test requires:

• Peripheral venous blood sample

Preparation generally includes:

• No fasting is required
• Inform your physician about previous pregnancies and blood transfusions
• Share any history of Rh incompatibility or antibody formation
• Follow laboratory instructions for sample collection

Normal Reporting Time

Results are generally available within 1 to 3 working days, depending on laboratory workflow and testing methodology.

Who Should Take This Test?

• Rh-negative pregnant women
• Women with positive antibody screening tests
• Individuals with suspected Rh sensitization
• Patients requiring immunohematology evaluation
• Individuals with a history of Rh incompatibility
• Patients referred by obstetricians or transfusion medicine specialists

The test is an essential component of prenatal monitoring in Rh-negative pregnancies.

Clinical Significance

Elevated Anti-D Antibody Titres may indicate:

• Rh Alloimmunization
• Rh Sensitization
• Increased Risk of Hemolytic Disease of the Fetus and Newborn (HDFN)
• Maternal Immune Response to Rh-positive Red Blood Cells

Serial monitoring of antibody titres helps determine whether fetal surveillance and additional interventions may be necessary.

Important Note

The significance of an antibody titre depends on the specific laboratory methodology and clinical circumstances. Results should always be interpreted alongside blood group status, obstetric history, fetal monitoring findings, and specialist medical evaluation.